Mr. James Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) ANNOUNCES AN EXPANSION OF ITS YMI VALIDATION PROJECT

Ndatalyze Corp. has expanded its previously announced validation project. The expansion envisions the overall project being divided into two distinct divisions - a) psychiatry, and b) machine-learning. Going forward, the Mitacs-sponsored machine-learning-based ("ML") project will focus on logic and correlation validation while the supervision ("psychiatric guidance") aspect of the ML will be governed by the psychiatric division and will focus on mental condition prediction calibration and the development of associated treatment predictions relating to drugs/drug combinations and psychotherapy. In the interest of accelerating the time frame, the psychiatric division plan is to target a single cohort (one age group, one gender, one ethnicity) and a single mental condition.

The Corporation believes it has sufficient current capital to finance both divisions and that its ongoing private placement will be used primarily as working capital. Updates will be provided as available.

The Corporation's quarterly report for the period ended August 31, 2023, is now available on SEDAR+

About YMI

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops and to improve mental wellbeing. YMI combines machine-learning with a proprietary Reference Database that contains >1200 person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle to generate a personalized graphic report predicting an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

We seek Safe Harbor.